Back to Search Start Over

LetsTalkShots : personalized vaccine risk communication.

Authors :
Salmon DA
Dudley MZ
Brewer J
Shaw J
Schuh HB
Proveaux TM
Jamison AM
Forr A
Goryn M
Breiman RF
Orenstein WA
Kao LS
Josiah Willock R
Cantu M
Decea T
Mowson R
Tsubata K
Bucci LM
Lawler J
Watkins JD
Moore JW
Fugett JH
Fugal A
Tovar Y
Gay M
Cary AM
Vann I
Smith LB
Kan L
Mankel M
Beekun S
Smith V
Adams SD
Harvey SA
Orton PZ
Source :
Frontiers in public health [Front Public Health] 2023 Jun 30; Vol. 11, pp. 1195751. Date of Electronic Publication: 2023 Jun 30 (Print Publication: 2023).
Publication Year :
2023

Abstract

Introduction: Vaccine hesitancy is a global health threat undermining control of many vaccine-preventable diseases. Patient-level education has largely been ineffective in reducing vaccine concerns and increasing vaccine uptake. We built and evaluated a personalized vaccine risk communication website called LetsTalkShots in English, Spanish and French (Canadian) for vaccines across the lifespan. LetsTalkShots tailors lived experiences, credible sources and informational animations to disseminate the right message from the right messenger to the right person, applying a broad range of behavioral theories.<br />Methods: We used mixed-methods research to test our animation and some aspects of credible sources and personal narratives. We conducted 67 discussion groups ( n = 325 persons), stratified by race/ethnicity (African American, Hispanic, and White people) and population (e.g., parents, pregnant women, adolescents, younger adults, and older adults). Using a large Ipsos survey among English-speaking respondents ( n = 2,272), we tested animations aligned with vaccine concerns and specific to population (e.g., parents of children, parents of adolescents, younger adults, older adults).<br />Results: Discussion groups provided robust feedback specific to each animation as well as areas for improvements across animations. Most respondents indicated that the information presented was interesting (85.5%), clear (96.0%), helpful (87.0%), and trustworthy (82.2%).<br />Discussion: Tailored vaccine risk communication can assist decision makers as they consider vaccination for themselves, their families, and their communities. LetsTalkShots presents a model for personalized communication in other areas of medicine and public health.<br />Competing Interests: DS has received research support from Merck and serves on advisory boards for Merck, Janssen Moderna, and Sanofi. MD has received research support from Merck. KT was employed by Bonnemaison. LB was employed by Bucci-Hepworth Health Services Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2023 Salmon, Dudley, Brewer, Shaw, Schuh, Proveaux, Jamison, Forr, Goryn, Breiman, Orenstein, Kao, Josiah Willcock, Cantu, Decea, Mowson, Tsubata, Bucci, Lawler, Watkins, Moore, Fugett, Fugal, Tovar, Gay, Cary, Vann, Smith, Kan, Mankel, Beekun, Smith, Adams, Harvey and Orton.)

Details

Language :
English
ISSN :
2296-2565
Volume :
11
Database :
MEDLINE
Journal :
Frontiers in public health
Publication Type :
Academic Journal
Accession number :
37457264
Full Text :
https://doi.org/10.3389/fpubh.2023.1195751